- Home
- NRSN vs GROW Comparison
NRSN vs GROW Comparison
Compare NRSN & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- GROW
- Stock Information
- Founded
- NRSN 2017
- GROW 1968
- Country
- NRSN Israel
- GROW United States
- Employees
- NRSN N/A
- GROW N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- NRSN Health Care
- GROW Finance
- Exchange
- NRSN Nasdaq
- GROW Nasdaq
- Market Cap
- NRSN 31.1M
- GROW 32.2M
- IPO Year
- NRSN 2021
- GROW N/A
- Fundamental
- Price
- NRSN $1.22
- GROW $2.71
- Analyst Decision
- NRSN Buy
- GROW
- Analyst Count
- NRSN 2
- GROW 0
- Target Price
- NRSN $14.00
- GROW N/A
- AVG Volume (30 Days)
- NRSN 404.8K
- GROW 53.0K
- Earning Date
- NRSN 09-17-2025
- GROW 11-06-2025
- Dividend Yield
- NRSN N/A
- GROW 3.33%
- EPS Growth
- NRSN N/A
- GROW N/A
- EPS
- NRSN N/A
- GROW N/A
- Revenue
- NRSN N/A
- GROW $8,452,000.00
- Revenue This Year
- NRSN N/A
- GROW N/A
- Revenue Next Year
- NRSN N/A
- GROW N/A
- P/E Ratio
- NRSN N/A
- GROW N/A
- Revenue Growth
- NRSN N/A
- GROW N/A
- 52 Week Low
- NRSN $0.80
- GROW $2.02
- 52 Week High
- NRSN $2.60
- GROW $2.78
- Technical
- Relative Strength Index (RSI)
- NRSN 44.56
- GROW N/A
- Support Level
- NRSN $1.12
- GROW N/A
- Resistance Level
- NRSN $1.26
- GROW N/A
- Average True Range (ATR)
- NRSN 0.06
- GROW 0.00
- MACD
- NRSN 0.01
- GROW 0.00
- Stochastic Oscillator
- NRSN 36.87
- GROW 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.